Research & MST Statistics are the statisticians for Discovery, Pre-Clinical Development, Translational biomarkers, Early Clinical Development and CMC within GSK’s R&D organisation. This global team sews the golden statistical thread from target identification through to proof of mechanism/1b, as well as supporting product development through work with colleagues in CMC. We help establish rigorous decision-making frameworks at each stage of development, to connect project plans with downstream risk modulation. It is our mission to ensure statistical rigour at all times throughout Research.We work closely with biologists, chemists, geneticists and physicians across R&D, of course, but have a particular affinity with quantitative cousins across the analytics community - bioinformatics, computational biology, AIML, pharmacometrics and so on. We are always interested in hearing from PhD statisticians who are curious about a career in pharma - there’s a lot more to statistics and drug development than Phase 3 clinical research, vital though that be. About Graeme: more than two decades of experience in the drug development industry, using my PhD in statistical methods to promote a Bayesian approach to R&D. "If this [probability] calculus be condemned, then the whole of the sciences must also be condemned" - Henri Poincaré, "Science and Hypothesis", 1902. A spare-time writer about politics, in 2015-16 I spent a sabbatical year as a speechwriter for a cabinet minister in the British government.